Posted on 14 January 2013.
Positive Catalysts May Drive These 3 Speculative Biotech Stocks Higher
Investors who have been around Wall Street long enough may remember the biotech bubble of the 1980s fuelled by the approval of a number of blockbuster drugs, including Amgen's (AMGN) Epogen and Aranesp anemia drugs. Unfortunately, not every …
Full News here – Read more on Seeking Alpha